If the FDA approves a drug for a neglected tropical disease, the company gets a voucher that accelerates review of another drug. This remains controversial.
The Bureau of Customs (BOC) recorded total collections of PHP239.054 billion from January to March 2026, surpassing its internal target by 1.3% and growing 3.3% year-on-year, based on preliminary ...